Skip to main content

Conservative Management of Vesicovaginal Fistula

Continuous bladder drainage is an option for a selected recent, small VVF with viable tissue. Most established fistulae need repair. Published conservative series use different size limits and drainage durations.[1][10]

For diagnostic evaluation, see the VVF clinical page. Endoscopic VVF treatment is a separate procedure option for selected cases.

Rationale and Selection​

Drainage lowers bladder pressure and reduces urine flow through the defect, permitting healing in favorable cases. It does not reliably eliminate the pressure gradient, and epithelialization of the fistula tract can maintain patency rather than promote closure.[1][10]

Assess size, duration, location, tissue viability, infection, obstruction and associated ureteral injury. Radiation, malignancy, extensive ischemic obstetric injury, fibrosis or a mature tract make spontaneous closure less likely.[1][2][5]

Drainage and Reassessment​

Use a catheter that provides comfortable, unobstructed dependent drainage; investigate persistent leakage, blockage, spasm or upper-tract obstruction. A suprapubic route may be appropriate when urethral drainage is unsuitable. Catheter size, route and review interval depend on the anatomy and clinical setting.[10]

Agree on an early review and a finite trial, guided by leakage and tissue condition. Reports have used several weeks to three months, but there is no high-quality evidence that every patient should wait that long. Persistent leakage without improvement should prompt repair planning, and suspected infection, obstruction or malignancy needs prompt evaluation.[4][6][7]

Assess closure clinically and, when needed, with an appropriately performed bladder dye test; select cystoscopy or imaging for the unresolved anatomical question. If vaginal leakage persists despite a negative bladder dye test, consider ureterovaginal fistula and use a double-dye test or contrast-enhanced CT with late excretory phase and/or MRI as indicated.[10]

Supportive Measures​

  • Treat symptomatic infection and address its source. IDSA advises against routine screening or treatment of asymptomatic bacteriuria during short- or long-term catheterization. Pregnancy and invasive urologic procedures involving mucosal trauma have separate indications; catheter-removal prophylaxis is a distinct decision with an evidence gap.[9]
  • Consider medication for troublesome bladder spasms after checking drainage; review anticholinergic adverse effects and contraindications.
  • Protect vulvar and perineal skin during ongoing urinary leakage with appropriate pads and a barrier cream.[10] Assess nutrition, anemia and tissue health individually. Vaginal estrogen may treat coexisting menopausal symptoms, but is not a proven fistula-closing therapy.

What the Closure Studies Actually Show​

SourcePopulation and treatmentFinding and limitation
Bodner-Adler 2017[1]VVF after benign gynecologic surgery; catheter drainage initially used in 239 women19/239 (8%) closed with catheter drainage alone. The much higher 92.9% pooled “conservative” estimate combined heterogeneous interventions, including fulguration, laser and sealants.
Mohr 2014[7]99 women at a referral center; initial 12-week drainage protocol8/99 (8.1%) closed before surgery. Mohr's 12-week protocol did not compare durations.
He 2020[4]Three selected case reports: two VVF and one vesicouterine fistulaAll three stopped leaking. Mixed anatomy and case-report selection prevent estimating a general VVF success rate.
Tozzi 2023[6]24 women ultimately undergoing combined vaginal/laparoscopic repair; 22 had previous repair attemptsPrior Foley drainage failed in all.

When to Move Toward Repair​

Reassess when leakage persists, the defect is large or mature, tissue is fibrotic or irradiated, or prolonged catheterization no longer fits the patient's goals. Address a causative foreign body and reassess tissue viability before reconstruction; suspected active malignancy needs oncologic evaluation, and terminal malignant fistula may call for urinary diversion or other palliation.[10] Treat infection and define anatomy before reconstructive planning. Do not insist on a fixed three- to six-month delay.[5][10]

Postoperative Catheter Drainage Is a Different Question​

In Barone's randomized trial, 524 women with a simple fistula already closed at postoperative day seven were assigned to seven or 14 days of catheterization. In the per-protocol analysis, dye-test-defined breakdown from eight days after catheter removal to three months after surgery occurred in 10/250 (4.0%) after seven days of drainage versus 8/251 (3.2%) after 14 days; seven days met the prespecified noninferiority criterion for this endpoint in simple repairs.[3]

WHO recommends 7–10 days for selected simple obstetric repairs.[11] The newer IUGA/ICS obstetric consensus sets a minimum of 10–14 days as expert opinion (statement 37).[12] EAU also suggests longer drainage for complex or irradiated repairs.[10] See the principles page for the source-specific recommendations.[10][11]

In Chang's retrospective study, 29/52 (55.7%) women with a positive dye test after obstetric VVF surgery and at least 14 days of catheterization had a negative test after one additional week. That is selected postoperative rescue evidence, not a 55.7% cure rate for an unrepaired fistula.[8]

See Also​

References​

1. Bodner-Adler B, Hanzal E, Pablik E, Koelbl H, Bodner K. Management of vesicovaginal fistulas (VVFs) in women following benign gynaecologic surgery: a systematic review and meta-analysis. PLoS One. 2017;12(2):e0171554. doi:10.1371/journal.pone.0171554

2. Wall LL. Obstetric vesicovaginal fistula as an international public-health problem. Lancet. 2006;368(9542):1201–1209. doi:10.1016/S0140-6736(06)69476-2

3. Barone MA, Widmer M, Arrowsmith S, et al. Breakdown of simple female genital fistula repair after 7-day vs 14-day postoperative bladder catheterisation: a randomised, controlled, open-label, non-inferiority trial. Lancet. 2015;386(9988):56–62. doi:10.1016/S0140-6736(14)62337-0

4. He Z, Cui L, Wang J, Gong F, Jia G. Conservative treatment of patients with bladder genital tract fistula: three case reports. Medicine. 2020;99(31):e21430. doi:10.1097/MD.0000000000021430

5. Zhang C, Saussine C, Tricard T. Urogenital fistulas: surgical management, outcomes, and prognostic factors: a 14-year monocentric experience. Int Urogynecol J. 2026. doi:10.1007/s00192-026-06580-0

6. Tozzi R, Spagnol G, Marchetti M, et al. Vaginal-laparoscopic repair (VLR) of primary and persistent vesicovaginal fistula: description of a new technique and surgical outcomes. J Clin Med. 2023;12(5):1760. doi:10.3390/jcm12051760

7. Mohr S, Brandner S, Mueller MD, Dreher EF, Kuhn A. Sexual function after vaginal and abdominal fistula repair. Am J Obstet Gynecol. 2014;211(1):74.e1–6. doi:10.1016/j.ajog.2014.02.011

8. Chang OH, Ganesh P, Wilkinson JP, Pope RJ. Extended bladder catheterization for women with positive dye tests after obstetric vesicovaginal fistula repair surgery. Int J Gynaecol Obstet. 2020;149(1):61–65. doi:10.1002/ijgo.13088

9. Nicolle LE, Gupta K, Bradley SF, et al. Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by IDSA. Clin Infect Dis. 2019;68:e83–e110. Official guideline, sections XI and XIII. doi:10.1093/cid/ciy1121

10. European Association of Urology. Non-neurogenic Female LUTS guideline, section 4.8: urinary fistula. 2026 edition. Full guideline section.

11. World Health Organization. WHO recommendation on duration of bladder catheterization after surgical repair of simple obstetric urinary fistula. 2018. Official recommendation summary.

12. Maljaars LP, Corcos J, Ghoniem G, et al. "Consensus statements on the definition of surgical success following obstetric urinary pelvic floor fistula repair: an IUGA-ICS proposal." Int Urogynecol J. 2026;37(5):1193–1205. doi:10.1007/s00192-025-06413-6